ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #8,836Hybrid

Clinical Hemorheology and Microcirculation

Abbreviation (ISO):CLIN. HEMORHEOL. MICROCIRC
•
Identifier (ISSN):1386-0291(Print)/1875-8622(Online)
•
Publisher:IOS Press
Clarivate IF (2026)
1.7↑ +1.7
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Clinical Hemorheology and Microcirculation

WoS Q3
12341.9120181.6420192.3820212.4120222.120232.120241.72026
Annual Impact Factor Metric
Current (2026):1.7
Scopus SJR & RankScopus Q2
0.66
#8,836

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
65

65 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate38.1%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
137articles/year
4.21% Gold OA•97.17% Original Research

Aims & Scope

Clinical Hemorheology and Microcirculation, a peer-reviewed international scientific journal, serves as an aid to understanding the flow properties of blood and the relationship to normal and abnormal physiology. The rapidly expanding science of hemorheology concerns blood, its components and the blood vessels with which blood interacts. It includes perihemorheology, i.e., the rheology of fluid and structures in the perivascular and interstitial spaces as well as the lymphatic system. The clinical aspects include pathogenesis, symptomatology and diagnostic methods, and the fields of prophylaxis and therapy in all branches of medicine and surgery, pharmacology and drug research. The endeavour of the Editors-in-Chief and publishers of Clinical Hemorheology and Microcirculation is to bring together contributions from those working in various fields related to blood flow all over the world. The editors of Clinical Hemorheology and Microcirculation are from those countries in Europe, Asia, Australia and America where appreciable work in clinical hemorheology and microcirculation is being carried out. Each editor takes responsibility to decide on the acceptance of a manuscript. He is required to have the manuscript appraised by two referees and may be one of them himself. The executive editorial office, to which the manuscripts have been submitted, is responsible for rapid handling of the reviewing process. Clinical Hemorheology and Microcirculation accepts original papers, brief communications, mini-reports and letters to the Editors-in-Chief. Review articles, providing general views and new insights into related subjects, are regularly invited by the Editors-in-Chief. Proceedings of international and national conferences on clinical hemorheology (in original form or as abstracts) complete the range of editorial features.

Topics Covered (Recognized by AI)
Medicine95.8%Internal medicine82.4%Biology77.7%Chemistry58.6%Biochemistry52.7%Physics49.6%Endocrinology48.8%Immunology42.8%Cardiology41.9%Psychology41%Genetics39.1%Psychiatry36.9%Surgery35.2%Radiology34%Pathology29.2%Thermodynamics26.5%Red blood cell22.9%Organic chemistry21.4%Materials science20.3%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

HEMATOLOGY

Q3
Rank73/103
IndexSCIE
JCRSCIE2026

PERIPHERAL VASCULAR DISEASE

Q3
Rank72/100
IndexSCIE
JCISCIE2026

HEMATOLOGY

Q2
Rank33/103
IndexSCIE
JCISCIE2026

PERIPHERAL VASCULAR DISEASE

Q2
Rank36/100
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.7
Articles / Year19
Total Citations3
2025
IF—
Articles / Year58
Total Citations46
2024
IF2.1
Articles / Year93
Total Citations344
2023
IF2.1
Articles / Year125
Total Citations726
2022
IF2.411
Articles / Year103
Total Citations826

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,836Scopus Q2SCImago Profile
Scopus Coverage:1991-2025
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q2
0.66

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.60

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,980 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations596
3-Year Documents362
Citable Documents357

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cardiology and Cardiovascular MedicineQ2
HematologyQ2
PhysiologyQ3
Physiology (medical)Q3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 38.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区HEMATOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Clinical Hemorheology and Microcirculation (abbr: CLIN. HEMORHEOL. MICROCIRC, ISSN: 1386-0291) is a peer-reviewed international scholarly journal in the field of Medicine, published by IOS Press in Netherlands since 1997. The periodical holds a Journal Impact Factor (JIF) of 1.70, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.660 (Q2), an H-index of 65.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 137 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,980 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
IOS Press
Publication Language
English
Frequency
Bimonthly
Founding Year
1997
Indexing & Databases
SCIEScopusPubMed
Editorial Address
IOS PRESS, NIEUWE HEMWEG 6B, AMSTERDAM, NETHERLANDS, 1013 BG

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: ae593eaf-ffef-4a59-943f-0de12e78430c
Database Updated: 2026-10-01